title: [Spontaneous expression of class II (HLA-DR) molecules in thyroid pathology].
abstract: The spontaneous expression of Class II molecules (HLA-DR) was studied in cultured thyrocytes obtained from patients with Graves Disease (n = 7), Hashimoto's Thyroiditis (n = 5), euthyroid nodular goiter, (n = 12), papillary carcinoma (n = 5), and laryngeal carcinoma (3 normal thyroid glands). If nodular goiters and papillary carcinoma are of autoimmune origin, as Graves Disease and Hashimoto's Thyroiditis, they should spontaneously express HLA-DR antigen on their cell surface as this has been considered one of the initial steps of autoimmunity. The study was performed using the cytotoxicity assay. Immediately after the thyroid glands were obtained, thyrocytes were labelled with 51-Cr and incubated overnight; the cells were destroyed by adding monoclonal antiHLA-DR antibody and rabbit complement. The cytotoxicity index (CI% + SD) which reflects 51-Cr release from lyzed cells was used to measure antigen expression. While Graves Disease's and Hashimoto's Disease's thyrocytes expressed HLA-DR in high proportion, normal thyrocytes and thyroid cells from other diseases did so in minimal proportion (28.12 +/- 10.71 vs 2.26 +/- 2.32, p < 0.001). These findings strongly suggest that nodular goiters and papillary carcinoma are not of autoimmune origin since they are unable to express HLA-DR on their cell surface. It is postulated that HLA-DR expression is the result of the influence of T lymphocytes previously sensitized to thyroid antigens.
authors.affiliation: Departamento de Medicina, Facultad de Medicina, Universidad de Chile.
authors.forename: J
authors.initials: J
authors.lastname: Aguayo
authors.forename: M V
authors.initials: MV
authors.lastname: Pérez
authors.forename: P
authors.initials: P
authors.lastname: Trincado
authors.forename: N
authors.initials: N
authors.lastname: Wohllk
authors.forename: G
authors.initials: G
authors.lastname: Pineda
mesh_terms: D001327:Autoimmune Diseases / Q000276:immunology*; D003601:Cytotoxicity Tests, Immunologic / Q000379:methods; D006684:HLA-DR Antigens / Q000032:analysis*; D006801:Humans; D013959:Thyroid Diseases / Q000276:immunology*; D013964:Thyroid Neoplasms / Q000276:immunology*
chemical_list: D006684:HLA-DR Antigens
vernacular_title: Expresión espontánea de moléculas de clase II (HLA-DR) en patología tiroidea.